{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:03:47Z","timestamp":1780329827281,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004489","name":"Mitacs Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.msard.2026.107103","type":"journal-article","created":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T15:02:51Z","timestamp":1772377371000},"page":"107103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Medication trajectories among persons with multiple sclerosis in a Quebec birth cohort"],"prefix":"10.1016","volume":"110","author":[{"given":"Yasmine","family":"Sadou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Leffondre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Larochelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5788-4984","authenticated-orcid":false,"given":"Miceline","family":"M\u00e9sidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107103_bib0013","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1017\/cjn.2017.301","article-title":"Establishing the incidence and prevalence of multiple sclerosis in Saskatchewan","volume":"45","author":"Al-Sakran","year":"2018","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107103_bib0029","first-page":"1","article-title":"Geographical variation in medication and health resource use in multiple sclerosis","author":"Balcom","year":"2024","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.msard.2026.107103_bib0019","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jpepsy\/jst085","article-title":"An introduction to latent variable mixture modeling (part 2): longitudinal latent class growth analysis and growth mixture models","volume":"39","author":"Berlin","year":"2014","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.msard.2026.107103_bib0031","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3233\/NRE-2006-21301","article-title":"Urban\/rural differences in the use of physician services by people with multiple sclerosis","volume":"21","author":"Buchanan","year":"2006","journal-title":"NeuroRehabilitation."},{"key":"10.1016\/j.msard.2026.107103_bib0015","unstructured":"Canada Post, 2018. Addressing guidelines. Accessed 12 October 2024 : https:\/\/www.canadapost.ca\/tools\/pg\/manual\/PGaddress-e.pdf."},{"key":"10.1016\/j.msard.2026.107103_bib0007","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/13524585221122207","article-title":"Polypharmacy and multiple sclerosis: a population-based study","volume":"29","author":"Chertcoff","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107103_bib0002","article-title":"Treatment with DELTA-9-tetrahydrocannabinol\/cannabidiol in multiple sclerosis: influence on the autonomy profile according to the international classification of functioning, disability and health","volume":"8","author":"Ciotti","year":"2021","journal-title":"Eur. J. Case Rep. Intern. Med."},{"key":"10.1016\/j.msard.2026.107103_bib0001","first-page":"723","article-title":"Multiple sclerosis","author":"Cotsapas","year":"2018","journal-title":"Handbook Clinic. Neurol."},{"key":"10.1016\/j.msard.2026.107103_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fpain.2025.1512878","article-title":"Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study","volume":"6","author":"De Clifford-Faug\u00e8re","year":"2025","journal-title":"Front. Pain Res."},{"key":"10.1016\/j.msard.2026.107103_bib0003","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7861\/clinmed.2020-0292","article-title":"Clinical presentation and diagnosis of multiple sclerosis","volume":"20","author":"Ford","year":"2020","journal-title":"Clin Med (L.)"},{"key":"10.1016\/j.msard.2026.107103_bib0006","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1038\/s41598-019-40283-5","article-title":"Multi-drug use among patients with multiple sclerosis: a cross-sectional study of associations to clinicodemographic factors","volume":"9","author":"Frahm","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.msard.2026.107103_bib0008","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/14740338.2020.1720646","article-title":"Polypharmacy among patients with multiple sclerosis: a qualitative systematic review","volume":"19","author":"Frahm","year":"2020","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.msard.2026.107103_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.sapharm.2024.05.006","article-title":"A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases","author":"Gagnon","year":"2024","journal-title":"Res. Soc. Adm Pharm"},{"key":"10.1016\/j.msard.2026.107103_bib0023","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v011.i08","article-title":"Flexmix: a general framework for finite mixture models and latent glass regression in R","volume":"11","author":"Leisch","year":"2004","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.msard.2026.107103_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020683","article-title":"Framework to construct and interpret latent class trajectory modelling","volume":"8","author":"Lennon","year":"2018","journal-title":"BMJ Open."},{"key":"10.1016\/j.msard.2026.107103_bib0009","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/jwh.2012.3972","article-title":"Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines","volume":"23","author":"Manteuffel","year":"2014","journal-title":"J. Womens Health (Larchmt)"},{"key":"10.1016\/j.msard.2026.107103_bib0014","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.0b013e3181cf6ec0","article-title":"The rising prevalence and changing age distribution of multiple sclerosis in Manitoba","volume":"74","author":"Marrie","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107103_bib0005","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","article-title":"A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview","volume":"21","author":"Marrie","year":"2015","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107103_bib0033","article-title":"Sex-specific medication trajectories in older adults newly diagnosed with diabetes","volume":"11","author":"Mesidor","year":"2023","journal-title":"Explor. Res. Clin. Soc. Pharm."},{"key":"10.1016\/j.msard.2026.107103_bib0030","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/01.wnl.0000306411.46934.ef","article-title":"Access to and utilization of neurologists by people with multiple sclerosis","volume":"70","author":"Minden","year":"2008","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107103_bib0028","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/postgradmedj-2020-138944","article-title":"Associations between socioeconomic deprivation and pharmaceutical prescribing in primary care in England","volume":"98","author":"Mooney","year":"2022","journal-title":"Postgr. Med J"},{"key":"10.1016\/j.msard.2026.107103_bib0020","series-title":"Group-based modeling of development","author":"Nagin","year":"2005"},{"issue":"9","key":"10.1016\/j.msard.2026.107103_bib0027","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/13524585241251986","article-title":"Trends in central nervous system-active polypharmacy among people with multiple sclerosis","volume":"30","author":"Naizer","year":"2024","journal-title":"Mult. Scler."},{"key":"10.1016\/j.msard.2026.107103_bib0018","unstructured":"Ontario College of Pharmacists, 2022. What is the AHFS pharmacologic-therapeutic classification system\u202f?Accessed 06 May 2024 : https:\/\/www.ocpinfo.com\/wp-content\/uploads\/2022\/12\/AHFS-american-hospital-formulary-service-rise-online-training.pdf."},{"key":"10.1016\/j.msard.2026.107103_bib0026","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.3390\/ijerph17113926","article-title":"Gender differences in medication use: a drug utilization study based on real world data","volume":"17","author":"Orlando","year":"2020","journal-title":"Int. J. Environ. Res. Public health"},{"key":"10.1016\/j.msard.2026.107103_bib0016","doi-asserted-by":"crossref","first-page":"178","DOI":"10.24095\/hpcdp.29.4.05","article-title":"A deprivation index for health planning in Canada","volume":"29","author":"Pampalon","year":"2009","journal-title":"Chronic. Dis. Can."},{"key":"10.1016\/j.msard.2026.107103_bib0011","doi-asserted-by":"crossref","first-page":"dyae014","DOI":"10.1093\/ije\/dyae014","article-title":"Cohort Profile Update: the Qu\u00e9bec Birth Cohort on Immunity and Health (CO\u00b7MMUNITY)","volume":"53","author":"Rousseau","year":"2024","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.msard.2026.107103_bib0012","article-title":"Characteristics of persons with multiple sclerosis covered by public drug insurance in a Quebec Birth Cohort","volume":"54","author":"Sadou","year":"2025","journal-title":"Prev. Med. Rep."},{"key":"10.1016\/j.msard.2026.107103_bib0004","first-page":"239","article-title":"Polypharmacy in multiple sclerosis: current knowledge and future directions","volume":"118","author":"Thelen","year":"2021","journal-title":"Mo Med."},{"key":"10.1016\/j.msard.2026.107103_bib0010","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/jgs.17194","article-title":"Are there sex differences in potentially inappropriate prescribing in adults with multimorbidity?","volume":"69","author":"Ukhanova","year":"2021","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.msard.2026.107103_bib0021","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/10705511.2016.1247646","article-title":"The GRoLTS-checklist: guidelines for reporting on latent trajectory studies","volume":"24","author":"Van De Schoot","year":"2017","journal-title":"Struct Equ Model."},{"key":"10.1016\/j.msard.2026.107103_bib0017","unstructured":"World Health Organization, 2017. Guidance on the use of international nonproprietary names (INNs). Accessed 14 June 2024\u202f: https:\/\/www.who.int\/publications\/m\/item\/guidance-on-the-use-of-inns ."},{"key":"10.1016\/j.msard.2026.107103_bib0025","doi-asserted-by":"crossref","DOI":"10.1177\/2040622320983121","article-title":"Exploring polypharmacy phenomenon in newly diagnosed relapsing\u2013remitting multiple sclerosis: a cohort ambispective single-centre study","volume":"12","author":"Zangh\u00ec","year":"2021","journal-title":"Ther. Adv. Chronic. Dis."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826001392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:25:19Z","timestamp":1780327519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S2211034826001392"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107103","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication trajectories among persons with multiple sclerosis in a Quebec birth cohort","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107103"}}